Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
This report contains market size and forecasts of Monoclonal Mouse Antibody in global, including the following market information:
Global Monoclonal Mouse Antibody Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Monoclonal Mouse Antibody Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Monoclonal Mouse Antibody companies in 2021 (%)
The global Monoclonal Mouse Antibody market was valued at 9246.8 million in 2021 and is projected to reach US$ 12260 million by 2028, at a CAGR of 4.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
IgM Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Monoclonal Mouse Antibody include Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer and Lilly, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Monoclonal Mouse Antibody manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Monoclonal Mouse Antibody Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Monoclonal Mouse Antibody Market Segment Percentages, by Type, 2021 (%)
IgM
IgG
IgA
Others
Global Monoclonal Mouse Antibody Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Monoclonal Mouse Antibody Market Segment Percentages, by Application, 2021 (%)
Therapeutic
Research
Diagnostic
ELISA kits
Global Monoclonal Mouse Antibody Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Monoclonal Mouse Antibody Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Monoclonal Mouse Antibody revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Monoclonal Mouse Antibody revenues share in global market, 2021 (%)
Key companies Monoclonal Mouse Antibody sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Monoclonal Mouse Antibody sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics